More News

29 May 2007 Miraculins Announces Positive Final Results in Pivotal Prostate Cancer Biomarker Study
29 May 2007 FUJIFILM, Cangen Biotechnologies Joint Development Agreement on Anti-cancer Drug Delivery System
26 May 2007 Iomai Announces Interim Results From Phase 1 Study of Its Patch-Based Vaccine for Seasonal Influenza
26 May 2007 Iomai Announces Interim Results From Phase 1 Study of Its Patch-Based Vaccine for Seasonal Influenza
25 May 2007 Micromet and Nycomed Enter Into Exclusive Worldwide Collaboration to Develop and Commercialize Anti-GM-CSF Antibodies for the Treatment of Inflammatory and Autoimmune Diseases
25 May 2007 Emisphere Announces Initiation of Phase III Clinical Program of Oral Calcitonin for the Treatment of Osteoarthritis
25 May 2007 Inovio Biomedical’s DNA Delivery Technology Shows Safety and Enhances Gene Expression & Tumor Responses in Interim Melanoma Clinical Study Results
24 May 2007 Abbott Initiates First Clinical Study of Everolimus Eluting Stent System for Patients with Peripheral Arterial Disease
24 May 2007 Organon and Philips team up to study drug effects at the molecular level
24 May 2007 ThromboGenics plans to absorb Belgian subsidiary Thromb-X
23 May 2007 Inovio Biomedical's DNA Delivery Technology Significantly Enhances Potency of Gene-Based Prostate Cancer Vaccine
23 May 2007 Scil Technology GmbH obtained Competent Authority Approval for Phase II Periodontitis Study
23 May 2007 Phase 1b insulin clinical trial commenced
23 May 2007 New Agreement Boosts Pipeline for Synosia Therapeutics
23 May 2007 Abbott Announces Positive Nine-Month Results from the World's First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
23 May 2007 Lupin Pharmaceuticals, Inc. Receives US FDA Approval for Ziprasidone HCl Capsules
22 May 2007 Sandoz Receives FDA Approval for Generic Toprol XL(R) 50 mg Tablet
22 May 2007 Nektar Therapeutics Announces Phase 2a Clinical Results Regarding the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative Hospital-Acquired Pneumonia Presented at the Annual American Thoracic Society International Conference
22 May 2007 Oculus Initiates Patient Enrollment in Phase II Study of Microcyn(R) Technology for Treatment of Mild Diabetic Foot Infections
22 May 2007 Oculus Initiates Patient Enrollment in Phase II Study of Microcyn(R) Technology for Treatment of Mild Diabetic Foot Infections
22 May 2007 Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at AUA Annual Meeting
22 May 2007 Medtronic Announces Start of 8,800-Patient Clinical Trial Evaluating Drug-Eluting Stent Safety
21 May 2007 Sun Pharmaceutical Industries Agrees to Acquire Taro Pharmaceutical Industries in Transaction Valued at $454 Million
19 May 2007 KV Pharmaceutical Company (KVA) Announces Approval for Two Strengths of Generic Versions of Toprol-XL(R)
18 May 2007 Roche and Siena Biotech S.p.A. Enter Research Collaboration Agreement in Neurodegenerative Diseases

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top